First Xarelto Stroke Lawsuit Filed as Total Case Number Grows
Hundreds of people filed lawsuits against Bayer and Johnson & Johnson claiming their blood-thinning drug Xarelto (rivaroxaban) caused them to suffer negative side effects like uncontrollable bleeding.
Now, the daughter of a Florida man who died from a stroke four days after he began taking Xarelto filed a lawsuit in Philadelphia claiming the drug did not work as advertised. It’s the first lawsuit claiming Xarelto failed to prevent a stroke in a patient with atrial fibrillation (abnormal heartbeat).
The U.S. Food and Drug Administration approved Xarelto to reduce the risk of stroke in patients with atrial fibrillation in 2011, but one FDA reviewer recommended against the drug’s approval.
See the original article here: https://www.drugwatch.com/news/2015/10/27/first-xarelto-stroke-lawsuit/
About TriMark Legal Funding
TriMark Legal Funding was founded in 2003 and is one of America's leading national lawsuit funding companies. TriMark provides pre-settlement funding and post-settlement funding, sometimes called 'lawsuit loans', to injured plaintiffs throughout the United States. We offer funding on hundreds of different types of legal claims including personal injury loans, employment litigation funding, work injury accident loans, workers compensation loans, mass tort litigation funding, and multidistrict litigation funding.
We also provide immediate inheritance advance funding for heirs and beneficiaries, as well as attorney funding and law firm financing for legal practices.
|Personal Injury Lawsuits||Mass Torts|
Click here to see the original article.